4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine has been researched along with fibrinogen in 1 studies
| Studies (4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine) | Trials (4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine) | Recent Studies (post-2010) (4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 12 | 1 | 1 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bokemeyer, C; Brümmendorf, TH; Dierlamm, J; Eifrig, B; Haubold, K; Holstein, K; Langer, F; Marx, G; Spath, B; Wierecky, J | 1 |
1 other study(ies) available for 4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine and fibrinogen
| Article | Year |
|---|---|
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Topics: Aged; Aged, 80 and over; Antithrombin III; Antithrombins; Disseminated Intravascular Coagulation; Factor V; Factor XIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Peptide Hydrolases; Platelet Count; Thromboplastin; Triazines | 2008 |